Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2018

  • ID: 4580365
  • Report
  • 245 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3D Biotek LLC
  • C. R. Bard Inc
  • Electroformed Stents Inc
  • LimFlow GmbH
  • PeriTec Biosciences Ltd
  • Tepha Inc
  • MORE
Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2018

Summary

The Medical Devices sector report, “Peripheral Vascular Stents - Medical Devices Pipeline Assessment, 2018" provides an overview of Peripheral Vascular Stents currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Peripheral Vascular Stents pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by The team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Peripheral Vascular Stents under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Peripheral Vascular Stents and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Peripheral Vascular Stents under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3D Biotek LLC
  • C. R. Bard Inc
  • Electroformed Stents Inc
  • LimFlow GmbH
  • PeriTec Biosciences Ltd
  • Tepha Inc
  • MORE
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Peripheral Vascular Stents Overview

3 Products under Development
3.1 Peripheral Vascular Stents - Pipeline Products by Stage of Development
3.2 Peripheral Vascular Stents - Pipeline Products by Segment
3.3 Peripheral Vascular Stents - Pipeline Products by Territory
3.4 Peripheral Vascular Stents - Pipeline Products by Regulatory Path
3.5 Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
3.6 Peripheral Vascular Stents - Ongoing Clinical Trials

4 Peripheral Vascular Stents - Pipeline Products under Development by Companies
4.1 Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
4.2 Peripheral Vascular Stents - Pipeline Products by Stage of Development

5 Peripheral Vascular Stents Companies and Product Overview
5.1 3D Biotek LLC Company Overview
5.2 480 Biomedical Inc Company Overview
5.3 Abbott Vascular Inc Company Overview
5.4 AndraTec GmbH Company Overview
5.5 Becton Dickinson and Co Company Overview
5.6 Boston Scientific Corp Company Overview
5.7 C. R. Bard Inc Company Overview
5.8 Cardiatis SA Company Overview
5.9 Cook Medical Inc Company Overview
5.10 Cordis Corp Company Overview
5.11 Corinnova Inc Company Overview
5.12 Cytograft Tissue Engineering Inc (Inactive) Company Overview
5.13 Efferent Labs Inc Company Overview
5.14 Electroformed Stents Inc Company Overview
5.15 Elixir Medical Corp Company Overview
5.16 FIT Biotech Oy Company Overview
5.17 ID Nest Medical SAS Company Overview
5.18 InspireMD Inc Company Overview
5.19 Intact Vascular LLC Company Overview
5.20 LimFlow GmbH Company Overview
5.21 Medtronic plc Company Overview
5.22 Micell Technologies Inc Company Overview
5.23 Natec Medical Ltd Company Overview
5.24 Nipro Corp Company Overview
5.25 NSVascular, Inc. Company Overview
5.26 PeriTec Biosciences Ltd Company Overview
5.27 QualiMed Innovative Medizinprodukte GmbH Company Overview
5.28 Qvanteq AG Company Overview
5.29 REVA Medical Inc Company Overview
5.30 Stron Medical Company Overview
5.31 Synergy Flow Ltd Company Overview
5.32 Taewoong Medical Co Ltd Company Overview
5.33 Tepha Inc Company Overview
5.34 Terumo Corp Company Overview
5.35 TissueGen Inc Company Overview
5.36 University of Michigan Company Overview
5.37 University of Pittsburgh Medical Center Company Overview
5.38 Vascular Bioresorbable Technologies Company Overview
5.39 Vascular Concepts Ltd Company Overview
5.40 Vascular Dynamics Ltd. Company Overview
5.41 Veniti Inc Company Overview
5.42 Veryan Medical Ltd Company Overview
5.43 Vesper Medical Inc Company Overview
5.44 VueKlar Cardiovascular Ltd (Inactive) Company Overview
5.45 Wake Forest University Health Sciences Company Overview
5.46 Xenogenics Corporation Company Overview
5.47 Zorion Medical Company Overview

6 Peripheral Vascular Stents- Recent Developments
6.1 Jun 01, 2018: Boston Scientific Announces Scheduled Presentations At Digestive Disease Week 2018
6.2 May 31, 2018: Merit Medical Announces Leadership Change and Appointment of Interim CFO
6.3 May 24, 2018: Medtronic Reports Fourth Quarter And Fiscal Year 2018 Financial Results
6.4 May 15, 2018: Getinge announces its commitment to EuroPCR
6.5 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow
6.6 May 10, 2018: Neovasc Announces Results for the First Quarter 2018
6.7 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy
6.8 May 04, 2018: Ross Harvey named new director of global Customer Support & Delivery at Cook Medical
6.9 May 03, 2018: Intact Vascular Announces Enrollment Completion of the Tack Optimized Balloon Angioplasty III (TOBA III) Clinical Trial
6.10 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results
6.11 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018
6.12 Apr 25, 2018: CONMED Announces First Quarter 2018 Financial Results
6.13 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors
6.14 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
6.15 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.16 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results
6.17 Apr 12, 2018: STENTYS: Financial Information for the First Quarter of 2018
6.18 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics
6.19 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results
6.20 Mar 28, 2018: Neovasc Announces Results for the Fourth Quarter and Fiscal Year 2017
6.21 Mar 27, 2018: Intact Vascular Welcomes TOBA BTK Trial One-Year Clinical Study Results Publication in Catheterization and Cardiovascular Intervention
6.22 Mar 01, 2018: Researchers from MIPT study a nanoscaffold for heart cells
6.23 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance
6.24 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017
6.25 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017
6.26 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.27 Jan 31, 2018: LINC 2018: BIOTRONIK presents excellent 12-month data on more than 1000 patients
6.28 Jan 31, 2018: CONMED Announces Fourth Quarter and Fiscal Year 2017 Financial Results
6.29 Jan 30, 2018: Surgeon Saves Patient’s Foot From Amputation Using new LimFlow Procedure
6.30 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region
6.31 Jan 29, 2018: LimFlow Completes Enrollment In US Feasibility Study and Receives Breakthrough Device Status from FDA for Its Percutaneous Deep Vein Arterialization System
6.32 Jan 26, 2018: Medtronic Launches IDE Study to Evaluate the Abre Venous Self-Expanding Stent System in Patients with Deep Venous Disease
6.33 Jan 25, 2018: Veracyte Announces 100,000th Afirma Test Performed to Reduce Unnecessary Surgeries in Thyroid Cancer Diagnosis
6.34 Jan 25, 2018: TOBA II BTK Trial Enrollment Ahead of Schedule for the Tack Endovascular System in Below the Knee Disease
6.35 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers
6.36 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results
6.37 Jan 22, 2018: Neovasc Appoints Fred Colen As Chief Executive Officer
6.38 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017
6.39 Jan 08, 2018: STENTYS Reports Revenues for the Fourth Quarter and Full Year 2017
6.40 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership
6.41 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results
6.42 Jan 03, 2018: Tryton Medical Announces New CEO and President
6.43 Jan 02, 2018: CONMED Appoints Todd W. Garner as Executive Vice President and Chief Financial Officer

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact Us
7.4 Disclaimer

List of Tables
Table 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
Table 2: Peripheral Vascular Stents - Pipeline Products by Segment
Table 3: Peripheral Vascular Stents - Pipeline Products by Territory
Table 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
Table 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
Table 6: Peripheral Vascular Stents - Ongoing Clinical Trials
Table 7: Peripheral Vascular Stents Companies - Pipeline Products by Stage of Development
Table 8: Peripheral Vascular Stents - Pipeline Products by Stage of Development
Table 9: 3D Biotek LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Status
Table 11: Bioresorbable Drug Eluting Peripheral Polymer Stent - Product Description
Table 12: 480 Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Stanza Bioresorbable Pediatric Scaffold - Product Status
Table 14: Stanza Bioresorbable Pediatric Scaffold - Product Description
Table 15: Stanza Bioresorbable Self-Expanding Scaffold - Product Status
Table 16: Stanza Bioresorbable Self-Expanding Scaffold - Product Description
Table 17: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 18: ESPRIT Bioresorbable Vascular Scaffold - Product Status
Table 19: ESPRIT Bioresorbable Vascular Scaffold - Product Description
Table 20: Abbott Vascular Inc - Ongoing Clinical Trials Overview
Table 21: ESPRIT Bioresorbable Vascular Scaffold - Observational Study of Treatment of Bioresorbable Vascular Scaffolds Restenosis
Table 22: ESPRIT Bioresorbable Vascular Scaffold - Safety and Feasibility of Bioabsorbable Everolimus-Eluting Stents for Patients with Internal Pudendal Artery-related Arteriogenic Erectile Dysfunction (PERFECT-ABSORB)
Table 23: AndraTec GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Pillar Bifurcation Reconstruction Device - Product Status
Table 25: Pillar Bifurcation Reconstruction Device - Product Description
Table 26: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview
Table 27: LifeStent ProSeries Stent - Product Status
Table 28: LifeStent ProSeries Stent - Product Description
Table 29: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Eluvia Drug-Eluting Vascular Stent System - Product Status
Table 31: Eluvia Drug-Eluting Vascular Stent System - Product Description
Table 32: Gallbladder Drainage System - Product Status
Table 33: Gallbladder Drainage System - Product Description
Table 34: SAVAL Drug Eluting Stent BTK - Product Status
Table 35: SAVAL Drug Eluting Stent BTK - Product Description
Table 36: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Status
Table 37: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Product Description
Table 38: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 39: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Bare Metal Self-expanding Nitinol Stents in the Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
Table 40: Eluvia Drug-Eluting Vascular Stent System - A Randomized Trial Comparing the ELUVIA Drug-eluting Stent Versus Zilver PTX Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
Table 41: Eluvia Drug-Eluting Vascular Stent System - A Real World Evaluation of the ELUVIA Drug Eluting Stent in All-comers with Superficial Femoral Artery and Proximal Popliteal Artery Disease
Table 42: Eluvia Drug-Eluting Vascular Stent System - Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
Table 43: Wallstent RP Endoprosthesis - Venous Outflow Obstruction - Sinai Vein Stent Registry
Table 44: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: VENOVO Venous Stent - Product Status
Table 46: VENOVO Venous Stent - Product Description
Table 47: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 48: Cardiatis FluidSmart 3D Stent - Product Status
Table 49: Cardiatis FluidSmart 3D Stent - Product Description
Table 50: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Evolution Biliary Stent System-Partially Covered - Product Status
Table 52: Evolution Biliary Stent System-Partially Covered - Product Description
Table 53: Zenith Connection Endovascular Covered Stent - Product Status
Table 54: Zenith Connection Endovascular Covered Stent - Product Description
Table 55: Zilver Vena Venous Self-Expanding Stent - Product Status
Table 56: Zilver Vena Venous Self-Expanding Stent - Product Description
Table 57: Cook Medical Inc - Ongoing Clinical Trials Overview
Table 58: Zilver Vena Venous Self-Expanding Stent - Evaluation of the Zilver Vena Venous Stent in the Treatment of Symptomatic Iliofemoral Venous Outflow Obstruction
Table 59: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 60: FlexStent Femoropopliteal Self Expanding Stent System - SFA - Product Status
Table 61: FlexStent Femoropopliteal Self Expanding Stent System - SFA - Product Description
Table 62: FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Status
Table 63: FlexStent Self Expanding Below-The-Knee Venous Stent System - Product Description
Table 64: FlexStent Self Expanding Venous Stent System - Product Status
Table 65: FlexStent Self Expanding Venous Stent System - Product Description
Table 66: Tibial SE FlexStent - Product Status
Table 67: Tibial SE FlexStent - Product Description
Table 68: Cordis Corp - Ongoing Clinical Trials Overview
Table 69: FlexStent Femoropopliteal Self Expanding Stent System - SFA - Evaluation of Safety and Efficacy of the FlexStent Femoropopliteal Self-expanding Stent System Study
Table 70: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Hybrid Dynamic Stent - Product Status
Table 72: Hybrid Dynamic Stent - Product Description
Table 73: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 74: LifeJacket Stent Graft - Peripheral - Product Status
Table 75: LifeJacket Stent Graft - Peripheral - Product Description
Table 76: Efferent Labs Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 77: RTI-LICD Plexisense - Product Status
Table 78: RTI-LICD Plexisense - Product Description
Table 79: Electroformed Stents Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 80: Helical Stent - Product Status
Table 81: Helical Stent - Product Description
Table 82: Patch Stent - Product Status
Table 83: Patch Stent - Product Description
Table 84: Pleated Stent - Product Status
Table 85: Pleated Stent - Product Description
Table 86: Elixir Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 87: PRAVA Bioresorbable Scaffold - Product Status
Table 88: PRAVA Bioresorbable Scaffold - Product Description
Table 89: Elixir Medical Corp - Ongoing Clinical Trials Overview
Table 90: PRAVA Bioresorbable Scaffold - Drug Eluting Scaffold with an Absorbable Platform for Primary Lower Extremity Arterial Revascularization: DESappear Study
Table 91: FIT Biotech Oy Pipeline Products & Ongoing Clinical Trials Overview
Table 92: GTU X-Stent - Product Status
Table 93: GTU X-Stent - Product Description
Table 94: GTU X2-Stent - Product Status
Table 95: GTU X2-Stent - Product Description
Table 96: ID Nest Medical SAS Pipeline Products & Ongoing Clinical Trials Overview
Table 97: ID Venous System - Product Status
Table 98: ID Venous System - Product Description
Table 99: InspireMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 100: PVGuard Peripheral - Product Status
Table 101: PVGuard Peripheral - Product Description
Table 102: Intact Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 103: Tack Endovascular System - ATK - Product Status
Table 104: Tack Endovascular System - ATK - Product Description
Table 105: Tack Endovascular System - BTK - Product Status
Table 106: Tack Endovascular System - BTK - Product Description
Table 107: Intact Vascular LLC - Ongoing Clinical Trials Overview
Table 108: Tack Endovascular System - ATK - Tack Optimized Balloon Angioplasty (TOBA) Study for Femoropopliteal Arteries Using the Tack-IT Endovascular Stapler
Table 109: Tack Endovascular System - ATK - Tack Optimized Balloon Angioplasty Study for Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System
Table 110: Tack Endovascular System - ATK - Tack Optimized Drug Coated Balloon Angioplasty in the Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System
Table 111: Tack Endovascular System - BTK - Tack Optimized Balloon Angioplasty Study for the below the Knee Arteries Using the Tack Endovascular System
Table 112: LimFlow GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 113: LimFlow Percutaneous Deep Vein Arterialisation System - Product Status
Table 114: LimFlow Percutaneous Deep Vein Arterialisation System - Product Description
Table 115: LimFlow GmbH - Ongoing Clinical Trials Overview
Table 116: LimFlow Percutaneous Deep Vein Arterialisation System - A Post-market Surveillance study of LimFlow System in the Treatment of Patients with End-stage Critical Limb Ischemia
Table 117: LimFlow Percutaneous Deep Vein Arterialisation System - Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System for Creating an AV Fistula for the Treatment of Critical Limb Ischemia
Table 118: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Abre Venous Self-Expanding Stent System - Product Status
Table 120: Abre Venous Self-Expanding Stent System - Product Description
Table 121: Medtronic plc - Ongoing Clinical Trials Overview
Table 122: Abre Venous Self-Expanding Stent System - A Safety and Effectiveness of the Abre Stent System in Patients with Iliofemoral Venous Outflow Obstruction
Table 123: Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 124: Peripheral Drug-Eluting Stent - Product Status
Table 125: Peripheral Drug-Eluting Stent - Product Description
Table 126: Natec Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 127: Marina - Product Status
Table 128: Marina - Product Description
Table 129: Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 130: Peripheral Stent - Product Status
Table 131: Peripheral Stent - Product Description
Table 132: NSVascular, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 133: Micropatterned TFN Stent - Product Status
Table 134: Micropatterned TFN Stent - Product Description
Table 135: PeriTec Biosciences Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 136: Periteneum-Lined Balloon-Expandable Stent - Product Status
Table 137: Periteneum-Lined Balloon-Expandable Stent - Product Description
Table 138: Peritoneum Lined Self-Expanding Stent - Product Status
Table 139: Peritoneum Lined Self-Expanding Stent - Product Description
Table 140: QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 141: Biliary 0.035” OTW Stent - Product Status
Table 142: Biliary 0.035” OTW Stent - Product Description
Table 143: SOZO With 0.014 PERSEUS-q PTA Balloon Catheter - Product Status
Table 144: SOZO With 0.014 PERSEUS-q PTA Balloon Catheter - Product Description
Table 145: Tracheobronchial Stent - Product Status
Table 146: Tracheobronchial Stent - Product Description
Table 147: Qvanteq AG Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Peripheral Vascular Stents - Pipeline Products by Stage of Development
Figure 2: Peripheral Vascular Stents - Pipeline Products by Segment
Figure 3: Peripheral Vascular Stents - Pipeline Products by Territory
Figure 4: Peripheral Vascular Stents - Pipeline Products by Regulatory Path
Figure 5: Peripheral Vascular Stents - Pipeline Products by Estimated Approval Date
Figure 6: Peripheral Vascular Stents - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3D Biotek LLC
  • 480 Biomedical Inc
  • Abbott Vascular Inc
  • AndraTec GmbH
  • Becton Dickinson and Co
  • Boston Scientific Corp
  • C. R. Bard Inc
  • Cardiatis SA
  • Cook Medical Inc
  • Cordis Corp
  • Corinnova Inc
  • Cytograft Tissue Engineering Inc
  • Efferent Labs Inc
  • Electroformed Stents Inc
  • Elixir Medical Corp
  • FIT Biotech Oy
  • ID Nest Medical SAS
  • InspireMD Inc
  • Intact Vascular LLC
  • LimFlow GmbH
  • Medtronic plc
  • Micell Technologies Inc
  • Natec Medical Ltd
  • Nipro Corp
  • NSVascular, Inc.
  • PeriTec Biosciences Ltd
  • QualiMed Innovative Medizinprodukte GmbH
  • Qvanteq AG
  • REVA Medical Inc
  • Stron Medical
  • Synergy Flow Ltd
  • Taewoong Medical Co Ltd
  • Tepha Inc
  • Terumo Corp
  • TissueGen Inc
  • University of Michigan
  • University of Pittsburgh Medical Center
  • Vascular Bioresorbable Technologies
  • Vascular Concepts Ltd
  • Vascular Dynamics Ltd.
  • Veniti Inc
  • Veryan Medical Ltd
  • Vesper Medical Inc
  • VueKlar Cardiovascular Ltd
  • Wake Forest University Health Sciences
  • Xenogenics Corporation
  • Zorion Medical
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll